Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.
Nature Communications
Schmelz, Karin K; Toedling, Joern J; Huska, Matt M; Cwikla, Maja C MC; Kruetzfeldt, Louisa-Marie LM; Proba, Jutta J; Ambros, Peter F PF; Ambros, Inge M IM; Boral, Sengül S; Lodrini, Marco M; Chen, Celine Y CY; Burkert, Martin M; Guergen, Dennis D; Szymansky, Annabell A; Astrahantseff, Kathy K; Kuenkele, Annette A; Haase, Kerstin K; Fischer, Matthias M; Deubzer, Hedwig E HE; Hertwig, Falk F; Hundsdoerfer, Patrick P; Henssen, Anton G AG; Schwarz, Roland F RF; Schulte, Johannes H JH; Eggert, Angelika A
Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
Science Advances
Singh, Shivendra S; Quarni, Waise W; Goralski, Maria M; Wan, Shibiao S; Jin, Hongjian H; Van de Velde, Lee-Ann LA; Fang, Jie J; Wu, Qiong Q; Abu-Zaid, Ahmed A; Wang, Tingting T; Singh, Ravi R; Craft, David D; Fan, Yiping Y; Confer, Thomas T; Johnson, Melissa M; Akers, Walter J WJ; Wang, Ruoning R; Murray, Peter J PJ; Thomas, Paul G PG; Nijhawan, Deepak D; Davidoff, Andrew M AM; Yang, Jun J